Iclusig 45mg-KOR (Ponatinib Tablet) 45mg

Iclusig 45mg-KOR is a prescription tablet used for certain blood cancers. It contains ponatinib, a kinase inhibitor, and is supplied by Patheon Inc. This medication is taken orally and is designed for targeted therapy in specific hematologic conditions. Always use as directed by a healthcare professional.

Strength

45mg

Manufacturer / TM Owner

Patheon Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ponatinib is a kinase inhibitor prescribed to treat certain types of leukemia, including chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is used when other treatments have not been effective or when specific genetic mutations are present. Ponatinib works by blocking signals that promote cancer cell growth. It is not a cure but may help manage the disease.

Side Effects

This medication may help reduce symptoms associated with blood cancers, such as fatigue or enlarged spleen. Some patients experience improved blood counts over time. Effects vary by individual, and regular monitoring is typically required. It is important to follow up with a healthcare provider to assess progress.

Precautions & Warnings

Store Iclusig 45mg-KOR at room temperature away from moisture and heat. Keep out of reach of children and pets. Do not use if the packaging is damaged or the tablets appear altered. Inform your doctor about all medications and supplements you are taking before starting this treatment.

Avoid Interactions

Ponatinib can interact with other drugs, including certain antidepressants, antibiotics, and blood thinners. Avoid grapefruit products, as they may affect how the medication works. Alcohol use should be discussed with a healthcare provider. Always consult your doctor before combining this medication with other substances.

Frequently Asked Questions

Ponatinib is used to treat certain types of leukemia, including CML and Ph+ ALL, when other treatments are not effective.

Take the tablet exactly as prescribed by your doctor, usually once daily with or without food.

Common effects may include fatigue, nausea, or skin rash; report persistent issues to your healthcare provider.

Alcohol use should be discussed with your doctor, as it may interact with the medication.

Iclusig 45mg-KOR is available through licensed pharmacies with a valid prescription.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.